deferoxamine has been researched along with Injuries, Radiation in 8 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Deferoxamine treatment presents a potential therapeutic avenue through which to target impaired wound healing in patients following radiotherapy." | 1.72 | Transdermal deferoxamine administration improves excisional wound healing in chronically irradiated murine skin. ( Abbas, DB; Churukian, A; Griffin, M; Guardino, N; Guo, JL; Gurtner, GC; Lavin, CV; Lintel, H; Longaker, MT; Momeni, A; Wan, DC, 2022) |
| "Deferoxamine is a U." | 1.42 | Deferoxamine mitigates radiation-induced tissue injury in a rat irradiated TRAM flap model. ( Best, R; Das, A; Lin, KY; Mericli, AF; Rodeheaver, G; Rodeheaver, P, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Lintel, H | 1 |
| Abbas, DB | 1 |
| Lavin, CV | 1 |
| Griffin, M | 1 |
| Guo, JL | 1 |
| Guardino, N | 1 |
| Churukian, A | 1 |
| Gurtner, GC | 1 |
| Momeni, A | 2 |
| Longaker, MT | 1 |
| Wan, DC | 2 |
| Urlaub, KM | 1 |
| Lynn, JV | 1 |
| Carey, EG | 1 |
| Nelson, NS | 3 |
| Polyatskaya, Y | 2 |
| Donneys, A | 4 |
| Mazzoli, AC | 1 |
| Buchman, SR | 4 |
| Dassoulas, KR | 1 |
| Mericli, AF | 2 |
| Wang, JS | 1 |
| Lei, SS | 1 |
| Kim, T | 1 |
| Cottler, PS | 1 |
| Lin, KY | 2 |
| Das, A | 1 |
| Best, R | 1 |
| Rodeheaver, P | 1 |
| Rodeheaver, G | 1 |
| Blough, JT | 1 |
| Perosky, JE | 2 |
| Deshpande, SS | 2 |
| Kang, SY | 1 |
| Felice, PA | 1 |
| Figueredo, C | 2 |
| Peterson, JR | 1 |
| Kozloff, KM | 2 |
| Levi, B | 1 |
| Chepeha, DB | 1 |
| Rodriguez, JJ | 1 |
| Vasseli, CA | 1 |
| Ratliff, HC | 1 |
| Rapp, S | 1 |
| Wesbey, GE | 1 |
| Engelstad, BL | 1 |
| Brasch, RC | 1 |
8 other studies available for deferoxamine and Injuries, Radiation
| Article | Year |
|---|---|
Transdermal deferoxamine administration improves excisional wound healing in chronically irradiated murine skin.
Topics: Animals; Cicatrix; Collagen; Deferoxamine; Humans; Mice; Nitric Oxide; Radiation Injuries; Skin; Wou | 2022 |
Histologic Improvements in Irradiated Bone Through Pharmaceutical Intervention in Mandibular Distraction Osteogenesis.
Topics: Amifostine; Animals; Deferoxamine; Drug Therapy, Combination; Male; Mandible; Osteogenesis, Distract | 2018 |
Treatment With Topical Deferoxamine Improves Cutaneous Vascularity and Tissue Pliability in an Irradiated Animal Model of Tissue Expander-Based Breast Reconstruction.
Topics: Administration, Topical; Animals; Breast Neoplasms; Deferoxamine; Disease Models, Animal; Female; Ma | 2019 |
Deferoxamine mitigates radiation-induced tissue injury in a rat irradiated TRAM flap model.
Topics: Animals; Deferoxamine; Disease Models, Animal; Male; Radiation Injuries; Rats; Rats, Sprague-Dawley; | 2015 |
Translational treatment paradigm for managing non-unions secondary to radiation injury utilizing adipose derived stem cells and angiogenic therapy.
Topics: Adipose Tissue; Animals; Debridement; Deferoxamine; Fractures, Ununited; Mandible; Radiation Injurie | 2016 |
Prevention of radiation-induced bone pathology through combined pharmacologic cytoprotection and angiogenic stimulation.
Topics: Amifostine; Angiography; Animals; Biomechanical Phenomena; Bone Density; Bone Diseases; Cytoprotecti | 2016 |
Clinical Use of Deferoxamine in Distraction Osteogenesis of Irradiated Bone.
Topics: Animals; Bone Regeneration; Deferoxamine; Humans; Male; Maxilla; Maxillary Diseases; Osteogenesis, D | 2016 |
Paramagnetic pharmaceuticals for magnetic resonance imaging.
Topics: Abdomen; Adult; Animals; Brain; Contrast Media; Deferoxamine; Electron Spin Resonance Spectroscopy; | 1984 |